Postpartum Hemorrhage: Uterotonics and Interventional Radiology
Postpartum hemorrhage remains one of the most urgent complications in obstetric care. Rapid blood loss can follow uterine atony, retained placental tissue, genital tract trauma, placenta accreta spectrum, coagulopathy, or a combination of these causes. Treatment therefore depends on early recognition, coordinated resuscitation, and a clear escalation pathway.
Uterotonic medicines are usually the first pharmacological response when the uterus is poorly contracted. They can restore tone and reduce bleeding quickly, yet their selection must account for hypertension, asthma, cardiac disease, thromboembolic risk, and other maternal conditions. When medication and conservative procedures do not control hemorrhage, interventional radiology can provide a uterus-sparing option through targeted arterial embolization.
The clinical discussions associated with the FAOPS and PREBIC AA meetings placed perinatal medicine within a broad scientific and multidisciplinary setting. The FAOPS 2020 archive preserves information about the planned Tokyo congress, including its emphasis on perinatal and neonatal research, even though the meeting was canceled in April 2020 because of the COVID-19 pandemic and international travel restrictions.
Recognizing The Hemorrhage Early
Postpartum hemorrhage is commonly defined as cumulative blood loss of at least 1,000 mL or bleeding associated with signs of hypovolemia within 24 hours after birth, regardless of delivery route. Traditional thresholds based on 500 mL after vaginal birth and 1,000 mL after cesarean delivery remain useful for awareness, but visual estimation frequently underestimates actual loss. Quantitative measurement, when available, supports earlier action.
The first assessment should occur alongside treatment rather than before it. Clinicians evaluate uterine tone, the placenta, the birth canal, vital signs, mental status, urine output, and the speed of ongoing blood loss. A firm uterus with persistent bleeding suggests laceration, retained tissue, uterine rupture, or an abnormal placental attachment. A boggy uterus points more strongly toward atony, the leading cause of primary postpartum hemorrhage.
A response team should establish large-bore intravenous access, send blood for a complete blood count, coagulation studies, fibrinogen, and type and crossmatch, and activate a massive transfusion protocol when clinically indicated. Warming the patient and blood products, correcting hypocalcemia, and monitoring acid-base status are important because hypothermia, acidosis, and low fibrinogen can intensify coagulopathy.
Choosing Uterotonic Treatment
Uterine massage and an intravenous or intramuscular oxytocin infusion are generally initial measures for atony. Oxytocin improves myometrial contraction and has a familiar safety profile, although rapid intravenous administration can cause hypotension, tachycardia, or fluid-related complications. The exact infusion strategy should follow local protocols and the patient’s hemodynamic condition.
If bleeding continues, a second-line uterotonic may be selected. Methylergonovine produces powerful uterine contraction but should generally be avoided in significant hypertension, preeclampsia, or certain vascular disorders. Carboprost, a prostaglandin F2-alpha analogue, is effective for refractory atony but requires caution or avoidance in patients with asthma and careful consideration in those with pulmonary or hepatic disease. Misoprostol may be useful where injectable agents are unavailable, although fever, shivering, nausea, and delayed onset can limit its acceptability.
Tranexamic acid is an antifibrinolytic rather than a uterotonic, but it is an important part of modern postpartum bleeding management. Intravenous administration as soon as possible, ideally within three hours of birth when hemorrhage is diagnosed, is associated with better survival outcomes. It should complement source control and blood component therapy, not delay them. Contraindications and renal dosing require clinical review.
| Intervention | Main role | Important cautions | Place in escalation |
|---|---|---|---|
| Oxytocin | First-line treatment for uterine atony | Hypotension, tachycardia, fluid load | Begin promptly with massage |
| Methylergonovine | Sustained uterine contraction | Hypertension, preeclampsia, vascular disease | Common second-line option |
| Carboprost | Treatment of persistent atony | Asthma and pulmonary disease | Use when benefits outweigh risks |
| Misoprostol | Prostaglandin-based uterine contraction | Fever, shivering, gastrointestinal effects | Alternative or additional agent |
| Tranexamic acid | Reduces fibrinolysis and clot breakdown | Thrombotic history, renal impairment | Give early alongside hemorrhage care |
| Uterine artery embolization | Controls arterial bleeding while preserving the uterus in selected cases | Delay, instability, infection, limited resources | Consider after failed medical or conservative treatment |
Moving Beyond Medication
When uterotonics fail, clinicians may use bimanual uterine compression, uterine balloon tamponade, compression sutures, uterine artery ligation, or hysterectomy. Balloon tamponade can be especially valuable in atony because it applies pressure inside the uterine cavity while the team continues resuscitation and searches for other causes. It is less likely to succeed when bleeding arises from an unrecognized arterial injury or invasive placentation.
The decision to escalate should be based on ongoing blood loss, hemodynamic status, response to treatment, and the suspected source. A patient who is deteriorating rapidly may need operative control without waiting for every medication or device to be tried. Conversely, a stable patient with persistent but localized bleeding may benefit from a planned radiological procedure.
Interventional radiology fits into this decision process as a source-control specialty. A radiologist introduces a catheter, commonly through the femoral artery, and uses angiography to identify active extravasation or abnormal pelvic arterial flow. Embolization material is then delivered to the relevant uterine or pelvic arteries. The goal is to stop hemorrhage while limiting tissue ischemia and preserving future reproductive potential when circumstances permit.
How Interventional Radiology Works
Uterine artery embolization is most useful when the patient is sufficiently stable for transport and imaging, and when a trained team and appropriate equipment are immediately available. It can be considered for persistent postpartum bleeding after cesarean or vaginal birth, traumatic arterial bleeding, uterine atony that has not responded to other measures, and selected cases involving placenta accreta spectrum after delivery.
The procedure usually involves arterial access, pelvic angiography, selective catheterization, and injection of embolic agents. Gelatin sponge particles are commonly used when temporary occlusion is preferred, while coils or other agents may be selected for focal arterial injuries. The choice depends on the bleeding pattern, vascular anatomy, operator expertise, and the need for durable or temporary control.
Embolization is not a replacement for resuscitation. Blood products, airway support, warming, antibiotics when indicated, and correction of coagulopathy must continue throughout the process. A woman in profound shock may require surgical intervention because transfer to an angiography suite could create a dangerous delay. Interventional radiology is most effective when integrated into a predefined hemorrhage pathway rather than summoned as an isolated rescue service.
Benefits, Risks, And Patient Selection
The principal advantage of embolization is effective control of selected pelvic bleeding without immediate hysterectomy. This may preserve fertility and avoid the surgical morbidity associated with laparotomy. It can also target a bleeding vessel that would be difficult to locate during an emergency operation, particularly after prior surgery or complex pelvic anatomy.
Possible complications include arterial injury, hematoma, infection, contrast reactions, renal injury, non-target embolization, and pelvic ischemia. Post-embolization pain and fever can occur. Rarely, tissue necrosis or ovarian dysfunction may develop. These risks should be explained in advance when placenta accreta is suspected antenatally or when a planned cesarean delivery is likely to carry a high hemorrhage risk.
Patient selection must remain dynamic. A stable woman with ongoing bleeding and adequate access to specialists may be an excellent candidate. A patient with uncontrolled shock, suspected uterine rupture, extensive genital tract trauma, or a need for immediate surgical repair may require the operating room first. Multidisciplinary judgment should include obstetrics, anesthesiology, transfusion medicine, neonatology, nursing, and interventional radiology.
Perinatal practice also depends on disciplined diagnostic thinking across maternal and neonatal care. The FAOPS educational material on neonatal cholestasis guidance illustrates how structured algorithms help clinicians move from an initial finding to time-sensitive investigation and treatment. A similar principle applies to hemorrhage: recognize the pattern, identify the likely cause, and escalate before deterioration narrows the available options.
Building A Coordinated Response
Hospitals should maintain a written postpartum hemorrhage protocol that defines medication doses, transfusion triggers, emergency contact pathways, equipment locations, and criteria for activating interventional radiology. The protocol should be rehearsed through simulation, including scenarios involving atony, placenta previa, accreta spectrum, concealed bleeding, and delayed postpartum hemorrhage.
A reliable response includes a leader who assigns roles, a recorder who tracks blood loss and medications, a transfusion coordinator, and clinicians responsible for airway and procedural care. Communication with the patient and family should remain clear and compassionate. When a hysterectomy becomes necessary, the team should explain that it may be the safest life-saving intervention rather than a failure of earlier treatment.
Prevention begins before delivery. Antenatal imaging can identify placenta previa and raise concern for abnormal placental invasion. Correction of anemia, review of bleeding risks, delivery in an appropriately equipped facility, and advance planning with blood bank and radiology services can reduce avoidable delays. For high-risk cases, the availability of a hybrid operating room or rapid transfer pathway may influence delivery planning.
- Measure cumulative blood loss rather than relying on visual estimation alone.
- Give uterotonics and tranexamic acid promptly when clinically appropriate.
- Investigate the cause of bleeding while resuscitation proceeds.
- Activate surgery and interventional radiology early for persistent or arterial hemorrhage.
- Debrief the team and document the response for future quality improvement.
Translating Evidence Into Safer Care
Research on uterotonics and pelvic embolization continues to refine the balance between speed, safety, fertility preservation, and resource use. Clinical teams should follow current national and international guidance while adapting protocols to local blood supplies, staffing, transfer times, and procedural expertise. Medication algorithms are valuable, but they cannot replace repeated bedside assessment.
Education should extend beyond obstetricians. Midwives, emergency physicians, anesthesiologists, radiographers, nurses, blood bank personnel, and neonatal teams all influence the speed and quality of care. A newborn may require stabilization while the mother is undergoing transfusion or an invasive procedure, making coordinated perinatal planning essential.
The most effective system treats postpartum hemorrhage as a time-critical process rather than a sequence of isolated interventions. Uterotonics restore contractility when atony is the cause; tamponade and surgery provide mechanical or definitive control; interventional radiology offers targeted embolization for suitable patients. Early recognition and coordinated escalation connect these options into one practical strategy.
Hospitals, professional societies, and training programs can use these principles to review local protocols, conduct multidisciplinary simulation, and strengthen access to blood products and pelvic vascular expertise. Putting a clear escalation pathway into everyday practice gives clinicians more options when hemorrhage begins and gives families the best available chance of a safe outcome.
